Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...

Broad-spectrum disease control and advanced root performance solutions now available for growers across North America.

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, ...